Four pharmaceutical companies have agreed to settle False Claims Act allegations for a combined $124 million, the largest health care fraud recovery that federal prosecutors in New Hampshire have ever obtained, the Justice Department said Monday.

Mylan Pharmaceuticals Inc., UDL Laboratories Inc., AstraZeneca Pharmaceuticals and Ortho McNeil Pharmaceutical Inc. entered into settlement agreements with the Justice Department following claims that the companies failed to pay appropriate rebates to state Medicaid programs for drugs that the state programs paid for. The companies, Justice Department officials said, agreed to pay quarterly rebates to Medicaid based on the amount of money the state programs were paying for the pharmaceutical companies’ drugs.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]